US$ 29.90
glp-1 news today 2025 obesity drug october Obesity GLP-1 Market GLP-1 Weight-Loss Drug Demonstration Begins
Description
Discover how GLP-1 drugs like semaglutide & tirzepatide are transforming obesity care with weight loss results rivaling bariatric surgery.

This statement has not been evaluated by the Food and Drug Administration

A new study provides the first clinical evidence that popular semaglutide drugs, like Ozempic or Wegovy, could slow down processes associated with biological aging.

Study results: what did they find
New content online: The role of GLP1 receptor agonists in adult-onset type 1 diabetes mellitus
